Table 1.
Yearly screening for rhinovirus/enterovirus (RV/EV) in respiratory samples from patients presenting to the University Hospital, Clermont-Ferrand, France.
| Data 1 | Age Group 2 | 2014 3 | 2015 | 2016 | 2017 | 2018 | Total |
|---|---|---|---|---|---|---|---|
| Total samples tested | Adults | 397 (55%) | 1043 (58%) | 2201 (70%) | 1678 (59%) | 1809 (63%) | 7128 (63%) |
| Children | 324 (45%) | 752 (42%) | 948 (30%) | 1153 (41%) | 1060 (27%) | 4237 (27%) | |
| Positive detection of RV/EV | Adults | 55 (14%) | 103 (10%) | 208 (9%) | 134 (8%) | 209 (12%) | 709 (10%) |
| Children | 138 (43%) | 225 (30%) | 332 (35%) | 335 (29%) | 362 (34%) | 1392 (33%) | |
| Enterovirus typing | Adults | 46 (84%) | 91 (88%) | 188 (90%) | 121 (90%) | 191 (91%) | 637 (90%) |
| Children | 127 (92%) | 183 (81%) | 289 (87%) | 276 (82%) | 324 (90%) | 1199 (86%) | |
| EV-D68 typing | Adults | 3 (12%) | 0 | 5 (22%) | 1 (100%) | 11 (48%) | 20 (27%) |
| Children | 23 (88%) | 0 | 18 (78%) | 0 | 12 (52%) | 53 (73%) | |
| Median age | 4 (0.7–6.9) | 3.1 (0.2–7.6) | 7.8 (0.5–54) | 4 (0.4–32.8) | |||
| Total | 26 | 0 | 23 | 1 | 23 | 73 |
1 Data are n (%) or median (IQR). 2 Adults, patients aged >16 years; children, patients aged 0–16 years. 3 In 2014, the data were recorded from June 1st.